{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:18:56Z","timestamp":1791256736637,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2009,4,30]],"date-time":"2009-04-30T00:00:00Z","timestamp":1241049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,4,30]],"date-time":"2009-04-30T00:00:00Z","timestamp":1241049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1038\/leu.2009.80","type":"journal-article","created":{"date-parts":[[2009,4,30]],"date-time":"2009-04-30T09:47:02Z","timestamp":1241084822000},"page":"1744-1754","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["MEK inhibitors potentiate dexamethasone lethality in acute lymphoblastic leukemia cells through the pro-apoptotic molecule BIM"],"prefix":"10.1038","volume":"23","author":[{"given":"A A","family":"Rambal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z L G","family":"Panaguiton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,4,30]]},"reference":[{"key":"BFleu200980_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1006\/bbrc.2000.3922","volume":"279","author":"SL Planey","year":"2000","unstructured":"Planey SL, Litwack G . Glucocorticoid-induced apoptosis in lymphocytes. Biochem Biophys Res Commun 2000; 279: 307\u2013312.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFleu200980_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/sj.cdd.4400969","volume":"9","author":"CW Distelhorst","year":"2002","unstructured":"Distelhorst CW . Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ 2002; 9: 6\u201319.","journal-title":"Cell Death Differ"},{"key":"BFleu200980_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/sj.leu.2402733","volume":"17","author":"WJ Tissing","year":"2003","unstructured":"Tissing WJ, Meijerink JP, den Boer ML, Pieters R . Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia. Leukemia 2003; 17: 17\u201325.","journal-title":"Leukemia"},{"key":"BFleu200980_CR4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/01.cco.0000142072.22226.09","volume":"16","author":"O Frankfurt","year":"2004","unstructured":"Frankfurt O, Rosen ST . Mechanisms of glucocorticoid-induced apoptosis in hematologic malignancies: updates. Curr Opin Oncol 2004; 16: 553\u2013563.","journal-title":"Curr Opin Oncol"},{"key":"BFleu200980_CR5","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMra023001","volume":"350","author":"CH Pui","year":"2004","unstructured":"Pui CH, Relling MV, Downing JR . Acute lymphoblastic leukemia. N Engl J Med 2004; 350: 1535\u20131548.","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"BFleu200980_CR6","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1038\/sj.cdd.4401456","volume":"11","author":"S Schmidt","year":"2004","unstructured":"Schmidt S, Rainer J, Ploner C, Presul E, Riml S, Kofler R . Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. Cell Death Differ 2004; 11 (Suppl 1): S45\u2013S55.","journal-title":"Cell Death Differ"},{"key":"BFleu200980_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0092-8674(04)00046-7","volume":"116","author":"NN Danial","year":"2004","unstructured":"Danial NN, Korsmeyer SJ . Cell death: critical control points. Cell 2004; 116: 205\u2013219.","journal-title":"Cell"},{"key":"BFleu200980_CR8","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/sj.onc.1210220","volume":"26","author":"JM Adams","year":"2007","unstructured":"Adams JM, Cory S . The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 2007; 26: 1324\u20131337.","journal-title":"Oncogene"},{"key":"BFleu200980_CR9","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/emboj\/17.2.384","volume":"17","author":"L O'Connor","year":"1998","unstructured":"O'Connor L, Strasser A, O'Reilly LA, Hausmann G, Adams JM, Cory S et al. Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J 1998; 17: 384\u2013395.","journal-title":"EMBO J"},{"key":"BFleu200980_CR10","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/sj.cdd.4401688","volume":"12","author":"R Ley","year":"2005","unstructured":"Ley R, Ewings KE, Hadfield K, Cook SJ . Regulatory phosphorylation of Bim: sorting out the ERK from the JNK. Cell Death Differ 2005; 12: 1008\u20131014.","journal-title":"Cell Death Differ"},{"key":"BFleu200980_CR11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nri1568","volume":"5","author":"A Strasser","year":"2005","unstructured":"Strasser A . The role of BH3-only proteins in the immune system. Nat Rev Immunol 2005; 5: 189\u2013200.","journal-title":"Nat Rev Immunol"},{"key":"BFleu200980_CR12","doi-asserted-by":"publisher","first-page":"15313","DOI":"10.1073\/pnas.0406837101","volume":"101","author":"H Harada","year":"2004","unstructured":"Harada H, Quearry B, Ruiz-Vela A, Korsmeyer SJ . Survival factor-induced extracellular signal-regulated kinase phosphorylates BIM, inhibiting its association with BAX and proapoptotic activity. Proc Natl Acad Sci USA 2004; 101: 15313\u201315317.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu200980_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1535-6108(02)00127-7","volume":"2","author":"A Letai","year":"2002","unstructured":"Letai A, Bassik MC, Walensky LD, Sorcinelli MD, Weiler S, Korsmeyer SJ . Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2002; 2: 183\u2013192.","journal-title":"Cancer Cell"},{"key":"BFleu200980_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2004.12.030","volume":"17","author":"L Chen","year":"2005","unstructured":"Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 2005; 17: 393\u2013403.","journal-title":"Mol Cell"},{"key":"BFleu200980_CR15","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.molcel.2005.02.003","volume":"17","author":"T Kuwana","year":"2005","unstructured":"Kuwana T, Bouchier-Hayes L, Chipuk JE, Bonzon C, Sullivan BA, Green DR et al. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell 2005; 17: 525\u2013535.","journal-title":"Mol Cell"},{"key":"BFleu200980_CR16","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1126\/science.286.5445.1735","volume":"286","author":"P Bouillet","year":"1999","unstructured":"Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Kontgen F et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999; 286: 1735\u20131738.","journal-title":"Science"},{"key":"BFleu200980_CR17","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S1535-6108(03)00244-7","volume":"4","author":"JR Jeffers","year":"2003","unstructured":"Jeffers JR, Parganas E, Lee Y, Yang C, Wang J, Brennan J et al. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 2003; 4: 321\u2013328.","journal-title":"Cancer Cell"},{"key":"BFleu200980_CR18","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1126\/science.1090072","volume":"302","author":"A Villunger","year":"2003","unstructured":"Villunger A, Michalak EM, Coultas L, Mullauer F, Bock G, Ausserlechner MJ et al. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 2003; 302: 1036\u20131038.","journal-title":"Science"},{"key":"BFleu200980_CR19","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/ni834","volume":"3","author":"JC Rathmell","year":"2002","unstructured":"Rathmell JC, Lindsten T, Zong WX, Cinalli RM, Thompson CB . Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis. Nat Immunol 2002; 3: 932\u2013939.","journal-title":"Nat Immunol"},{"key":"BFleu200980_CR20","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1016\/j.febslet.2006.05.031","volume":"580","author":"J Lu","year":"2006","unstructured":"Lu J, Quearry B, Harada H . p38-MAP kinase activation followed by BIM induction is essential for glucocorticoid-induced apoptosis in lymphoblastic leukemia cells. FEBS Lett 2006; 580: 3539\u20133544.","journal-title":"FEBS Lett"},{"key":"BFleu200980_CR21","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1182\/blood-2004-05-2023","volume":"105","author":"PS Bachmann","year":"2005","unstructured":"Bachmann PS, Gorman R, Mackenzie KL, Lutze-Mann L, Lock RB . Dexamethasone resistance in B-cell precursor childhood acute lymphoblastic leukemia occurs downstream of ligand-induced nuclear translocation of the glucocorticoid receptor. Blood 2005; 105: 2519\u20132526.","journal-title":"Blood"},{"key":"BFleu200980_CR22","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1182\/blood-2005-07-2853","volume":"107","author":"S Schmidt","year":"2006","unstructured":"Schmidt S, Rainer J, Riml S, Ploner C, Jesacher S, Achmuller C et al. Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia. Blood 2006; 107: 2061\u20132069.","journal-title":"Blood"},{"key":"BFleu200980_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/35065000","volume":"410","author":"L Chang","year":"2001","unstructured":"Chang L, Karin M . Mammalian MAP kinase signalling cascades. Nature 2001; 410: 37\u201340.","journal-title":"Nature"},{"key":"BFleu200980_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0165-6147(00)01865-4","volume":"23","author":"JM English","year":"2002","unstructured":"English JM, Cobb MH . Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci 2002; 23: 40\u201345.","journal-title":"Trends Pharmacol Sci"},{"key":"BFleu200980_CR25","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/sj.leu.2402460","volume":"16","author":"JT Lee Jr","year":"2002","unstructured":"Lee Jr JT, McCubrey JA . The Raf\/MEK\/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia. Leukemia 2002; 16: 486\u2013507.","journal-title":"Leukemia"},{"key":"BFleu200980_CR26","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.1182\/blood-2002-12-3647","volume":"101","author":"LC Platanias","year":"2003","unstructured":"Platanias LC . Map kinase signaling pathways and hematologic malignancies. Blood 2003; 101: 4667\u20134679.","journal-title":"Blood"},{"key":"BFleu200980_CR27","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/sj.bjc.6601488","volume":"90","author":"E O'Neill","year":"2004","unstructured":"O'Neill E, Kolch W . Conferring specificity on the ubiquitous Raf\/MEK signalling pathway. Br J Cancer 2004; 90: 283\u2013288.","journal-title":"Br J Cancer"},{"key":"BFleu200980_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1053\/j.seminoncol.2003.08.012","volume":"30","author":"LF Allen","year":"2003","unstructured":"Allen LF, Sebolt-Leopold J, Meyer MB . CI-1040 (PD184352), a targeted signal transduction inhibitor of MEK (MAPKK). Semin Oncol 2003; 30: 105\u2013116.","journal-title":"Semin Oncol"},{"key":"BFleu200980_CR29","doi-asserted-by":"publisher","first-page":"5281","DOI":"10.1200\/JCO.2005.14.415","volume":"23","author":"PM Lorusso","year":"2005","unstructured":"Lorusso PM, Adjei AA, Varterasian M, Gadgeel S, Reid J, Mitchell DY et al. Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies. J Clin Oncol 2005; 23: 5281\u20135293.","journal-title":"J Clin Oncol"},{"key":"BFleu200980_CR30","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.2174\/156802607781696837","volume":"7","author":"JY Wang","year":"2007","unstructured":"Wang JY, Wilcoxen KM, Nomoto K, Wu S . Recent advances of MEK inhibitors and their clinical progress. Curr Top Med Chem 2007; 7: 1364\u20131378.","journal-title":"Curr Top Med Chem"},{"key":"BFleu200980_CR31","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1126\/science.286.5443.1358","volume":"286","author":"A Bonni","year":"1999","unstructured":"Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME . Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 1999; 286: 1358\u20131362.","journal-title":"Science"},{"key":"BFleu200980_CR32","doi-asserted-by":"publisher","first-page":"23366","DOI":"10.1074\/jbc.272.37.23366","volume":"272","author":"FK Racke","year":"1997","unstructured":"Racke FK, Lewandowska K, Goueli S, Goldfarb AN . Sustained activation of the extracellular signal-regulated kinase\/mitogen-activated protein kinase pathway is required for megakaryocytic differentiation of K562 cells. J Biol Chem 1997; 272: 23366\u201323370.","journal-title":"J Biol Chem"},{"key":"BFleu200980_CR33","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/bj3510095","volume":"351","author":"SP Davies","year":"2000","unstructured":"Davies SP, Reddy H, Caivano M, Cohen P . Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000; 351: 95\u2013105.","journal-title":"Biochem J"},{"key":"BFleu200980_CR34","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1038\/nsmb859","volume":"11","author":"JF Ohren","year":"2004","unstructured":"Ohren JF, Chen H, Pavlovsky A, Whitehead C, Zhang E, Kuffa P et al. Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition. Nat Struct Mol Biol 2004; 11: 1192\u20131197.","journal-title":"Nat Struct Mol Biol"},{"key":"BFleu200980_CR35","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1101\/gad.1304105","volume":"19","author":"SN Willis","year":"2005","unstructured":"Willis SN, Chen L, Dewson G, Wei A, Naik E, Fletcher JI et al. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 2005; 19: 1294\u20131305.","journal-title":"Genes Dev"},{"key":"BFleu200980_CR36","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ccr.2005.09.006","volume":"8","author":"QB She","year":"2005","unstructured":"She QB, Solit DB, Ye Q, O'Reilly KE, Lobo J, Rosen N . The BAD protein integrates survival signaling by EGFR\/MAPK and PI3K\/Akt kinase pathways in PTEN-deficient tumor cells. Cancer Cell 2005; 8: 287\u2013297.","journal-title":"Cancer Cell"},{"key":"BFleu200980_CR37","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/ncb1005","volume":"5","author":"LA Allan","year":"2003","unstructured":"Allan LA, Morrice N, Brady S, Magee G, Pathak S, Clarke PR . Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK. Nat Cell Biol 2003; 5: 647\u2013654.","journal-title":"Nat Cell Biol"},{"key":"BFleu200980_CR38","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrc2297","volume":"8","author":"AG Letai","year":"2008","unstructured":"Letai AG . Diagnosing and exploiting cancer's addiction to blocks in apoptosis. Nat Rev Cancer 2008; 8: 121\u2013132.","journal-title":"Nat Rev Cancer"},{"key":"BFleu200980_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.tcb.2008.01.007","volume":"18","author":"JE Chipuk","year":"2008","unstructured":"Chipuk JE, Green DR . How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol 2008; 18: 157\u2013164.","journal-title":"Trends Cell Biol"},{"key":"BFleu200980_CR40","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1158\/0008-5472.CAN-06-4244","volume":"67","author":"PS Bachmann","year":"2007","unstructured":"Bachmann PS, Gorman R, Papa RA, Bardell JE, Ford J, Kees UR et al. Divergent mechanisms of glucocorticoid resistance in experimental models of pediatric acute lymphoblastic leukemia. Cancer Res 2007; 67: 4482\u20134490.","journal-title":"Cancer Res"},{"key":"BFleu200980_CR41","doi-asserted-by":"publisher","first-page":"6172","DOI":"10.1128\/MCB.24.14.6172-6183.2004","volume":"24","author":"R Kuribara","year":"2004","unstructured":"Kuribara R, Honda H, Matsui H, Shinjyo T, Inukai T, Sugita K et al. Roles of Bim in apoptosis of normal and Bcr-Abl-expressing hematopoietic progenitors. Mol Cell Biol 2004; 24: 6172\u20136183.","journal-title":"Mol Cell Biol"},{"key":"BFleu200980_CR42","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1038\/sj.onc.1208421","volume":"24","author":"A Essafi","year":"2005","unstructured":"Essafi A, Fernandez de Mattos S, Hassen YA, Soeiro I, Mufti GJ, Thomas NS et al. Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells. Oncogene 2005; 24: 2317\u20132329.","journal-title":"Oncogene"},{"key":"BFleu200980_CR43","doi-asserted-by":"publisher","first-page":"14907","DOI":"10.1073\/pnas.0606176103","volume":"103","author":"J Kuroda","year":"2006","unstructured":"Kuroda J, Puthalakath H, Cragg MS, Kelly PN, Bouillet P, Huang DC et al. Bim and Bad mediate imatinib-induced killing of Bcr\/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic. Proc Natl Acad Sci USA 2006; 103: 14907\u201314912.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu200980_CR44","doi-asserted-by":"publisher","first-page":"16090","DOI":"10.1073\/pnas.0505585102","volume":"102","author":"Y Zhao","year":"2005","unstructured":"Zhao Y, Tan J, Zhuang L, Jiang X, Liu ET, Yu Q . Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim. Proc Natl Acad Sci USA 2005; 102: 16090\u201316095.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu200980_CR45","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s10495-006-0283-6","volume":"11","author":"S Gillespie","year":"2006","unstructured":"Gillespie S, Borrow J, Zhang XD, Hersey P . Bim plays a crucial role in synergistic induction of apoptosis by the histone deacetylase inhibitor SBHA and TRAIL in melanoma cells. Apoptosis 2006; 11: 2251\u20132265.","journal-title":"Apoptosis"},{"key":"BFleu200980_CR46","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1038\/sj.leu.2403868","volume":"19","author":"C Yu","year":"2005","unstructured":"Yu C, Dasmahapatra G, Dent P, Grant S . Synergistic interactions between MEK1\/2 and histone deacetylase inhibitors in BCR\/ABL+ human leukemia cells. Leukemia 2005; 19: 1579\u20131589.","journal-title":"Leukemia"},{"key":"BFleu200980_CR47","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.bbrc.2005.11.131","volume":"339","author":"K Ozaki","year":"2006","unstructured":"Ozaki K, Minoda A, Kishikawa F, Kohno M . Blockade of the ERK pathway markedly sensitizes tumor cells to HDAC inhibitor-induced cell death. Biochem Biophys Res Commun 2006; 339: 1171\u20131177.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu200980.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu200980","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu200980.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:08:45Z","timestamp":1648728525000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu200980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,30]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["BFleu200980"],"URL":"https:\/\/doi.org\/10.1038\/leu.2009.80","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,30]]},"assertion":[{"value":"21 August 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}